SOURCE: Millennium Dental Technologies

Millennium Dental Technologies

April 07, 2015 08:00 ET

Rutgers Becomes First University to Bring the LANAP® and LAPIP™ Protocols to a Postgraduate Periodontics Program

CERRITOS, CA--(Marketwired - Apr 7, 2015) - MILLENNIUM DENTAL TECHNOLOGIES, Inc. (MDT) is pleased to announce a new partnership with Rutgers School of Dental Medicine in Newark, New Jersey. This written agreement, signed by Kathleen Bramwell, MBA, Senior Vice Chancellor, Finance and Administration, ensures that upon graduation, periodontal residents will already be trained in these protocols. 

Three Rutgers University professors, Andrew Sullivan, DDS - Director of Postgraduate Periodontics and Interim Chairman; Howard Drew, DMD - Clinical Professor of Periodontics, Director of Implantology, and Vice Chairman of the Department of Periodontics; and Joel Pascuzzi, DMD, FIDC, FADC - Clinical Professor of Periodontics and the Director of the Pre-Doctorate Periodontal Program, completed training with the Institute for Advanced Laser Dentistry (IALD) in Cerritos, California, in February 2015. Affectionately referred to as Laser BootCamp®, the IALD training is a live-patient, clinical, hands-on course on the PerioLase® MVP-7™ and the LANAP® and LAPIP™ protocols. Following the initial Rutgers University site visit, MDT and IALD personnel visited Rutgers University to help familiarize the dental assistants, hygienists, and residents with the LANAP® and LAPIP™ protocols and proper care of their new PerioLase® MVP-7™.

Millennium, which is also developing a partnership with the U.S. Army, has plans to continue building relationships with other educational institutions as well. "Rutgers is helping to lead the way for academic institutions to provide advanced periodontal disease treatment that patients will accept," stated Dawn M. Gregg, DDS, IALD CEO and training director. "Bringing the PerioLase® MVP-7™ for the LANAP® and LAPIP™ protocols to the Rutgers University postgraduate periodontal program advances the standard of care for treating periodontitis and peri-implantitis."

Professor and Chair, Dr. Andrew Sullivan says, "We can't lag behind in our profession. It is important for our periodontal residents to graduate on the leading edge, having been trained on the most advanced, evidence-based periodontal disease treatments available. Of additional benefit is having access to a solution to the growing number of ailing and failing implants and for treating other dental maladies using the PerioLase® MVP-7™."

The LANAP® protocol with the PerioLase® MVP-7™ is the only U.S. FDA-cleared laser periodontitis treatment with any scientific evidence of regenerating the periodontal ligament attachment to the root surface and a new root coating (cementum). In addition, there are over 400 published positive patient outcomes and two histology studies. The human histology research proves the LANAP® protocol creates cementum-mediated periodontal new attachment to the root surface in the absence of long junctional epithelium. Patients experience little to no post-operative discomfort because the procedure requires no use of scalpels or the placement of sutures, allowing for faster, easier recovery. Of significant note, according to a recent systematic review by the American Academy of Periodontology's Regeneration Workshop, the LANAP® protocol "may offer advantages in regeneration of defects in the esthetic zone in which minimal soft tissue change is required."* The PerioLase® MVP-7™ is also developed for the LAPIP™ protocol, for the minimally invasive surgical treatment for peri-implantitis and mucositis around ailing and failing implants.

*Periodontal Regeneration - Intrabony Defects: A Systematic Review From the AAP Regeneration Workshop - J Periodontol February 2015 (2 Suppl) Richard T. Kao, DDS, PhD, Salvador Nares, DDS, PhD, and Mark A. Reynolds, DDS, PhD, MA, page S82.

ABOUT MILLENNIUM DENTAL TECHNOLOGIES INC.: Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc., is the developer of the LANAP® protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT's FDA-cleared and patented LANAP® protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional scalpel/suture flap surgery; its PerioLase® MVP-7 is a 6-watt free-running variable-pulsed Nd:YAG dental laser featuring digital technology and 7 pulse durations--the most available on the market--giving it the power and versatility to perform a wide range of soft- and hard-tissue laser procedures. The PerioLase® MVP-7™ is also developed for the LAPIP™ protocol, for the treatment of ailing and failing implants. Established in 1994, the company's founding clinician, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients--and to remain true to the guiding principle--"It's all about the patient." For more information, visit www.lanap.com.

ABOUT THE INSTITUTE FOR ADVANCED LASER DENTISTRY: The Institute for Advanced Laser Dentistry, lead by CEO and Training Director, Dawn M. Gregg, DDS, is a non-profit educational and research center dedicated to providing evidence-based clinical training in advanced laser dentistry therapies. Formed in 1999 by dentists Robert H. Gregg, II, DDS and Delwin K. McCarthy, DDS, the IALD is both ADA CERP and AGD PACE accredited, and is nationally recognized for its continuing education (CE) programs. With more than 35 certified instructors who train dental professionals in laser dentistry techniques including the LANAP® protocol, the IALD aims to reach more underserved patients with gum disease who have avoided therapy out of fear. To that end, the organization provides free treatment to qualified patients who can benefit from the no-cut, no-sew, no-fear LANAP® protocol--providing about $750,000 in free dental services each year. The IALD's ultimate goal is for the percentage of patients seeking treatment for periodontitis to reach the percentage of patients seeking general dental care. For more information, please visit www.theiald.com.

Contact Information

  • Media Contacts:
    Leslie Licano
    Beyond Fifteen Communications, Inc.
    949-733-8679
    Email Contact

    Wendy Allen
    Millennium Dental Technologies, Inc.
    562-860-2908
    Email Contact